Fat Metabolism in the Critically Ill

  • Y. A. Carpentier
Conference paper
Part of the Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine book series (A+I, volume 178)


Sir David Cuthbertson has described two consecutive metabolic phases taking place after severe injury and/or during major sepsis [1]:

  1. 1.

    the initial ebb phase of variable duration, characterized by low cardiac output and tissue perfusion and during which most cellular functions are depressed. During this phase, catecholamine release by the adrenals and the sympathetic nervous system is high while insulin release is virtually abolished.



High Density Lipo Massive Infusion Metabolic Utilization Adipose Tissue Triglyceride Exogenous Particle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cuthbertson DP (1932) Q J Med 1: 233Google Scholar
  2. 2.
    Carpentier YA, et al (1984) Am J Physiol 247: E405–411Google Scholar
  3. 3.
    Nordenstrom J, et al (1983) Ann Surg 198: 725–735PubMedCrossRefGoogle Scholar
  4. 4.
    Wolfe RR (1984) data presented at the Symposium “The Scientific Basis of the Care of the Critically 111”, Manchester (United Kingdom)Google Scholar
  5. 5.
    Carpentier YA (1979) J Trauma 19: 649–654PubMedCrossRefGoogle Scholar
  6. 6.
    Lindholm M, Rossner S, Eklund J (1982) JPEN 6: 432CrossRefGoogle Scholar
  7. 7.
    Carpentier YA, et al (1979) Surg Forum 30: 72–74PubMedGoogle Scholar
  8. 8.
    Askanazi J, et al (1980) Ann Surg 191: 40–46PubMedCrossRefGoogle Scholar
  9. 9.
    Nordenstrom J, et al (1981) Clin Physiol 1: 525–534PubMedCrossRefGoogle Scholar
  10. 10.
    Carpentier YA, et al (1981) Acta Chir Belg 2–3: 141–144Google Scholar
  11. 11.
    Jarnberg PO, et al (1981) Crit Care Med 9: 27PubMedCrossRefGoogle Scholar
  12. 12.
    Hulman G, et al (1982) Lancet 11: 1426–1427CrossRefGoogle Scholar
  13. 13.
    Mayfield C,et al (1984) Clin Nutr 3 (2): 93–97PubMedGoogle Scholar
  14. 14.
    Jarstrand C, et al (1978) JPEN 2: 663–670CrossRefGoogle Scholar
  15. 15.
    Griffin (1979) J Clin Invest 64: 1703–1712PubMedCrossRefGoogle Scholar
  16. 16.
    Untracht SH (1982) Biochim Biophys Acta 711: 176–192PubMedGoogle Scholar
  17. 17.
    Deckelbaum R (1984) Communication presented at the 6th ESPEN Congress, MilanGoogle Scholar
  18. 18.
    Kasry A (1984) Communication presented at the 6th ESPEN Congress MilanGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • Y. A. Carpentier

There are no affiliations available

Personalised recommendations